First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
JACC: Cardiovascular Interventions · 2023-07 · 16 (13) · 1626-1635
DOI: 10.1016/j.jcin.2023.05.004 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2023-07. Verfasst von Syed Zaid und 26 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The latest-generation Evolut FX TAVR system (Medtronic) offers several potential design improvements over its predecessors, but early reported experience has been limited. OBJECTIVES: This study sought to report our multicenter, limited market release, first-in-human experience of transcatheter aortic valve replacement (TAVR) with the Evolut FX system and compare it with a single-center PRO+ (Medtronic) experience. METHODS: From June 27 to September 16, 2022, 226 consecutive patients from 9 US centers underwent transfemoral TAVR with the Evolut FX system for native aortic stenosis (89.4%) or prosthetic valve degeneration (10.6%). Commissural alignment was defined as 0° to 30° between native and FX commissures. Patient, anatomical, and procedural characteristics were retrospectively reviewed, and 30-day clinical and echocardiographic outcomes per Valve Academic Research Consortium-3 definitions were reported. RESULTS: Of 226 patients, 34.1% were low risk, 4% had a bicuspid valve, and 11.5% had a horizontal root (≥60°). Direct Inline sheath (Medtronic) was used in 67.6% and Lunderquist stiff wire (Cook Medical) in 35.4% of cases. Optimal hat marker orientation during deployment was achieved in 98.4%, with commissural alignment in 96.5%. At 30 days, 14.3% mild, 0.9% moderate, and no severe paravalvular leak were observed. Compared with the Evolut PRO+ experience from 1 center, FX had a more symmetrical implantation with shallower depth at the left coronary cusp (P < 0.001), fewer device recaptures (26.1% vs 39.5%; P = 0.004), and improved commissural alignment (96.5% vs 80.2%; P < 0.001). CONCLUSIONS: The Evolut FX system demonstrated favorable 30-day outcomes with a significant improvement over PRO+ in achieving commissural alignment, fewer device recaptures, and more symmetrical implantation. These features may benefit younger patients undergoing TAVR with the supra-annular, self-expanding valve, where lifetime management would be important.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
- University Hospitals of Cleveland, Cleveland, Ohio, USA.
- Mount Sinai Hospital, New York, New York, USA.
- University of Michigan, Ann Arbor, Michigan, USA.
- Cleveland Clinic, Cleveland, Ohio, USA.
- Abrazo Arizona Heart Hospital, Phoenix, Arizona, USA.
Zitieren
APA
Zaid, S., Attizzani, G. F., Krishnamoorthy, P., Yoon, S. H., Palma Dallan, L. A., Chetcuti, S., Fukuhara, S., Grossman, P. M., Goel, S. S., Atkins, M. D., Kleiman, N. S., Puri, R., Bakhtadze, B., Byrne, T., Ibrahim, A. W., Grubb, K. J., Tully, A., Herrmann, H. C., Faggioni, M., …, & Tang, G. H. L. (2023). First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System. JACC: Cardiovascular Interventions, 16(13), 1626-1635. https://doi.org/10.1016/j.jcin.2023.05.004
Vancouver
Zaid S, Attizzani GF, Krishnamoorthy P, Yoon SH, Palma Dallan LA, Chetcuti S, et al. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System. JACC: Cardiovascular Interventions. 2023;16(13):1626-1635. doi:10.1016/j.jcin.2023.05.004
BibTeX
@article{Zaid2023,
author = {Zaid, Syed and Attizzani, Guilherme F and Krishnamoorthy, Parasuram and Yoon, Sung-Han and Palma Dallan, Luis A and Chetcuti, Stanley and Fukuhara, Shinichi and Grossman, P Michael and Goel, Sachin S and Atkins, Marvin D and Kleiman, Neal S and Puri, Rishi and Bakhtadze, Beka and Byrne, Timothy and Ibrahim, Akram W and Grubb, Kendra J and Tully, Andy and Herrmann, Howard C and Faggioni, Michela and Ramlawi, Basel and Khera, Sahil and Lerakis, Stamatios and Dangas, George D and Kini, Annapoorna S and Sharma, Samin K and Reardon, Michael J and Tang, Gilbert H L},
title = {First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {13},
pages = {1626--1635},
doi = {10.1016/j.jcin.2023.05.004}
}
EUVIMED